Delivery Order SPE2DB24D3013-SPE2DB25FFFVM

This federal contract award, valued at $1,738.80, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Carvedilol ER 20 mg capsules, a cardiovascular medication, with a completion date of October 23, 2024.

The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains.

The contract award did not have a set-aside designation, indicating open competition. Amerisourcebergen is the prime contractor, and there is no information provided about any major subcontractors. The DLA, as a defense agency, is responsible for providing logistics, acquisition, and technical services to the U.S. military and other federal agencies, including supporting the healthcare needs of military personnel, veterans, and other federal beneficiaries.